Accuray Incorporated Total Assets
Accuray Incorporated total assets. Based on the latest financial reports, Accuray Incorporated (ARAY) holds total assets worth $443.68 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ARAY stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Accuray Incorporated (2002–2026)
Total assets of Accuray Incorporated from 2002 to 2026. This chart illustrates how Accuray Incorporated's total assets have evolved over time, based on quarterly financial data. See today's stock price for Accuray Incorporated for real-time trading data and today's change.
Accuray Incorporated - Asset Composition Analysis
Accuray Incorporated Total Assets Breakdown (June 2026)
Accuray Incorporated total assets breakdown as of June 2026. Accuray Incorporated's total assets of $443.68 Million consist of 64.8% current assets and 35.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.3% |
| Accounts Receivable | $67.41 Million | 15.2% |
| Inventory | $147.07 Million | 33.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $57.91 Million | 13.1% |
Asset Composition Trend (2002–2026)
This chart illustrates how Accuray Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Accuray Incorporated to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Accuray Incorporated's current assets represent 64.8% of total assets in 2026, an increase from 17.3% in 2002.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2026, down from 17.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 33.2% of total assets.
Accuray Incorporated Competitors by Total Assets
Key competitors of Accuray Incorporated based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Accuray Incorporated - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.65 | 1.86 |
| Quick Ratio | 0.74 | 0.92 | 1.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $96.37 Million | $124.89 Million | $162.20 Million |
Accuray Incorporated - Advanced Valuation Insights
This section examines the relationship between Accuray Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.76 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -5.6% |
| Total Assets | $443.68 Million |
| Market Capitalization | $17.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Accuray Incorporated's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Accuray Incorporated's assets decreased by 5.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Accuray Incorporated (2002–2026)
The table below shows the annual total assets of Accuray Incorporated from 2002 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | $443.68 Million | -5.65% |
| 2025-06-30 | $470.24 Million | +0.34% |
| 2024-06-30 | $468.63 Million | -2.21% |
| 2023-06-30 | $479.21 Million | +1.35% |
| 2022-06-30 | $472.85 Million | -1.51% |
| 2021-06-30 | $480.10 Million | -2.21% |
| 2020-06-30 | $490.93 Million | +12.04% |
| 2019-06-30 | $438.18 Million | +15.70% |
| 2018-06-30 | $378.73 Million | -6.82% |
| 2017-06-30 | $406.46 Million | -13.34% |
| 2016-06-30 | $469.03 Million | -0.20% |
| 2015-06-30 | $469.97 Million | -5.09% |
| 2014-06-30 | $495.19 Million | +4.05% |
| 2013-06-30 | $475.93 Million | +0.58% |
| 2012-06-30 | $473.17 Million | +3.81% |
| 2011-06-30 | $455.78 Million | +73.18% |
| 2010-06-30 | $263.18 Million | -4.08% |
| 2009-06-30 | $274.39 Million | -6.99% |
| 2008-06-30 | $295.00 Million | -11.17% |
| 2007-06-30 | $332.11 Million | +139.58% |
| 2006-06-30 | $138.62 Million | +59.59% |
| 2005-06-30 | $86.86 Million | +168.53% |
| 2003-06-30 | $32.35 Million | +171.25% |
| 2002-06-30 | $11.93 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more